The burden of diabetes and its complications: Trends and implications for intervention

被引:106
作者
Chaturvedi, Nish [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Natl Heart & Lung Inst, Int Ctr Circulatory Hlth, London W2 1PG, England
关键词
diabetes; epidemiology; vascular complications; prevention;
D O I
10.1016/j.diabres.2007.01.019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Much of the burden of diabetes is due to the development of vascular complications, including cardiovascular diseases, retinopathy and nephropathy. Improvements in patient management to promote tight control of glycaemia have helped to reduce the prevalence of microvascular complications, but cardiovascular diseases continue to be the leading cause of death in patients with type 2 diabetes. Globally, the number of people with diabetes is predicted to almost double over the next 30 years, with much of this increase occurring in developing countries. The growing prevalence of obesity is the major factor driving the increasing prevalence of type 2 diabetes, and the increase in obesity in adolescents is of particular concern. Consequently, the overall number of people with the vascular complications of diabetes is also predicted to increase. Prevention of diabetes is the best strategy for reducing the risk of complications, and screening of high-risk individuals is already being promoted in some Countries. Lifestyle changes, focusing on diet, exercise and weight loss are effective in preventing diabetes in Such people. However, more information is required about the long-term sustainability of these changes, and programmes also need to be adapted to meet the needs of developing countries. (C) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:S3 / S12
页数:10
相关论文
共 39 条
[1]   The metabolic syndrome - a new worldwide definition [J].
Alberti, KGMM ;
Zimmet, P ;
Shaw, J .
LANCET, 2005, 366 (9491) :1059-1062
[2]   Heart failure prevalence, incidence, and mortality in the elderly with diabetes [J].
Bertoni, AG ;
Hundley, WG ;
Massing, MW ;
Bonds, DE ;
Burke, GL ;
Goff, DC .
DIABETES CARE, 2004, 27 (03) :699-703
[3]   Acarbose for prevention of type 2 diabetes mellitus: the STOPNIDDM randomised trial [J].
Chiasson, JL ;
Josse, RG ;
Gomis, R ;
Hanefeld, M ;
Karasik, A ;
Laakso, M .
LANCET, 2002, 359 (9323) :2072-2077
[4]   Prevalence of diabetes and impaired fasting glucose levels among US adolescents - National Health and Nutrition Examination Survey, 1999-2002 [J].
Duncan, GE .
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2006, 160 (05) :523-528
[5]   Diabetes in heart failure: Prevalence and impact on outcome in the population [J].
From, Aaron M. ;
Leibson, Cynthia L. ;
Bursi, Francesca ;
Redfield, Margaret M. ;
Weston, Susan A. ;
Jacobsen, Steven J. ;
Rodeheffer, Richard J. ;
Roger, Veronique L. .
AMERICAN JOURNAL OF MEDICINE, 2006, 119 (07) :591-599
[6]   Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose:: a randomised controlled trial [J].
Gerstein, H. C. ;
Yusuf, S. ;
Holman, R. R. ;
Bosch, J. ;
Anand, S. ;
Avezum, A. ;
Budaj, A. ;
Chiasson, J. ;
Conget, I. ;
Dagenais, G. ;
Davis, M. ;
Diaz, R. ;
Dinccag, N. ;
Enjalbert, M. ;
Escalante, A. ;
Fodor, G. ;
Hanefeld, M. ;
Hedner, T. ;
Jolly, K. ;
Keltai, M. ;
Laakso, M. ;
Lanas, F. ;
Lonn, E. ;
McQueen, M. ;
Mohan, V. ;
Phillips, A. ;
Piegas, L. ;
Pirags, V. ;
Probstfield, J. ;
Shaw, J. ;
Schmid, I. ;
Teo, K. ;
Zimmet, P. ;
Zinman, B. ;
Gerstein, H. C. ;
Yusuf, S. ;
Bosch, J. ;
Pogue, J. ;
Sheridan, P. ;
Dinccag, N. ;
Hanefeld, M. ;
Hoogwerf, B. ;
Laakso, M. ;
Mohan, V. ;
Shaw, J. ;
Zinman, B. ;
Holman, R. R. ;
Diaz, R. ;
Ahuad Guerrero, R. ;
Albisu, J. .
LANCET, 2006, 368 (9541) :1096-1105
[7]  
Group DPPR., 2002, N Engl J Med, V346, P393, DOI [DOI 10.1056/NEJMOA012512, 10.1056/NEJMoa012512]
[8]   Diabetes and decline in heart disease mortality in US adults [J].
Gu, K ;
Cowie, CC ;
Harris, MI .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (14) :1291-1297
[9]   ONSET OF NIDDM OCCURS AT LEAST 4-7 YR BEFORE CLINICAL-DIAGNOSIS [J].
HARRIS, MI ;
KLEIN, R ;
WELBORN, TA ;
KNUIMAN, MW .
DIABETES CARE, 1992, 15 (07) :815-819
[10]   Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults - The Third National Health and Nutrition Examination Survey, 1988-1994 [J].
Harris, MI ;
Flegal, KM ;
Cowie, CC ;
Eberhardt, MS ;
Goldstein, DE ;
Little, RR ;
Wiedmeyer, HM ;
Byrd-Holt, DD .
DIABETES CARE, 1998, 21 (04) :518-524